C&Y Pharmaceutical Investment Holdings

Shanxi C&Y Pharmaceutical Group is a China-based pharmaceutical company specializing in the research, development, production, and sale of specialty and generic drugs. Founded in 2005 and headquartered in Datong with a group base in Shanghai, the company operates across multiple therapeutic segments including anti-infectives, respiratory health, urinary system disorders, and cardiovascular diseases. Its commercial portfolio features widely used medications such as Fosfomycin tromethamine, Ebastine, and Tamsulosin hydrochloride. Beyond drug manufacturing, the group has expanded into healthcare services, offering gene preservation and pregnancy environment testing. C&Y Pharmaceutical is listed on the Shenzhen Stock Exchange (300254) and continues to invest in innovative areas such as RNA-based therapeutics through strategic partnerships and investments.